the Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: GX-188E; Drug: Keytruda Sponsors: Genexine, Inc.; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials